Abstract Noninvasive ventilation (NIV) in the management of chronic obstructive pulmonary disease (COPD) patients with acute hypercapnic respiratory failure is considered a first-line therapy. However, patients who fail NIV and then require invasive mechanical ventilation have been found to have higher mortality than patients initially treated with invasive mechanical ventilation. We tried to find parameters associated with early NIV failure (need for intubation or death \24 h of starting NIV) in patients presenting to the ED with acute exacerbation of COPD. A retrospective analysis was conducted of the medical records of 218 patients with acute exacerbation of COPD visiting Asan Medical Center and managed with NIV during their stay in the ED from January 2007 to December 2013. NIV was successful in 200 (91.7 %) and 18 (8.3 %) had early NIV failure. Of the variables obtained before NIV treatment, heart rate (C120/min: OR 2.5, 95 % CI 1.2-7.0) and pH (7.25-7.29: OR 2.1, 95 % CI 1.0-8.8; \7.25: OR 11.7, 95 % CI 3.5-38.6) were significant factors associated with early NIV failure. Of the variables obtained after 1 h of NIV treatment, heart rate (C120/min: OR 7.5, 95 % CI 2.3-24.3) and pH \7.25: OR 20.9, were still significant. The presence of tachycardia and severe acidosis before NIV treatment and persistence of tachycardia and severe acidosis after 1 h of NIV treatment were associated with early NIV failure.
Introduction
Various studies have shown that noninvasive ventilation (NIV) reduces intubation rate and mortality compared to conventional treatments with invasive mechanical ventilation in the management of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD), and it is now considered a first-line therapy in patients with COPD and acute hypercapnic respiratory failure [1] [2] [3] [4] . Despite its profound advantages, failure rates of 5-50 % have been reported, and mortality rates have been found to be higher in patients who are intubated after failure of NIV, compared to patients treated with invasive mechanical ventilation from the start [5] [6] [7] . Several factors were reported to be associated with increased risk of NIV failure: Glasgow Coma Score, Acute Physiology and Chronic Health Evaluation (APACHE) II score, respiratory rate, initial pH, radiologically confirmed consolidation, hemodynamic instability, and hyperglycemia [7] [8] [9] . However, large variability in reported failure rates and different results regarding predictors of outcome exist owing to different degrees of disease severity included in the study (inclusion vs. exclusion of patients with pH \7.25), and definition of NIV failure in the aspect of time (early vs. late). Compared with studies including only mild to moderate acidotic patients, NIV is now offered to patients with more severe acidosis and appears to be effective in improving their clinical outcomes [7, 9, 10, 11] .
Owing to inconsistent results of previous studies, and current trends in application of NIV to more severe patients, reassessing the predictor variables for early NIV failure including sicker patients would be of clinical significance. Through this study, including patients with a wider range of severity and focusing on early failure, we tried to find parameters associated with NIV failure, more suitable to the emergency department (ED), in patients presenting with acute exacerbation of COPD.
Methods
Electronic medical record review of consecutive adult patients with COPD and acute hypercapnic respiratory failure visiting the Asan Medical Center ED in Seoul, Korea, between January 2007 and December 2013 was conducted. All of the patients included were treated with NIV during their stay in the ED. Confirmation of the presence of COPD was made based on the spirometry results from the patient's record; however, for those without spirometry test before presentation, diagnosis of COPD was made clinically based on the history, physical examinations, smoking exposure, and images of lung including chest X-ray or computed tomography. The definition of acute exacerbation of COPD was made according to the Global Initiative for Chronic obstructive Lung Disease (GOLD) criteria [12] . All patients received conventional medical therapy including oxygen therapy, bronchodilatator, steroids, and antibiotics if needed, and for those in whom conventional medical therapy was not effective, NIV (BiPAP Vision; Respironics, Murrysville, PA, USA) treatment with face mask was initiated. However, at the discretion of the treating physician, NIV was performed simultaneously with conventional medical therapy from presentation to the ED. NIV was usually started with an inspiratory positive pressure of 8 cmH 2 O and expiratory positive airway pressure of 4 cmH 2 O, and was titrated according to arterial blood gas analysis and clinical response. When applied, NIV was kept at least 1 h, and it was applied several times a day based on patient's tolerance and clinical judgment.
Demographic data, vital signs, Glasgow Coma Score (GCS), Comorbidity, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, previous treatment for COPD, laboratory results including serial arterial blood gas analysis (ABGA) measured immediately before and 1 h after NIV treatment, and chest radiograph findings were collected.
Primary outcome was early NIV failure, defined as the need for endotracheal intubation or death within 24 h after starting NIV. On the basis of the laboratory results and nursing charts recording trends in vital signs and patient status, the reasons for NIV failure were determined. The decision for endotracheal intubation was made when patients were at least in one of the following conditions: no improvement or worsening of arterial blood gas values (a decrease of 0.04 or more of pH, an increase of more than 6 mmHg of PaCO 2 ), unable to clear out tracheal secretion, deteriorating hemodynamic status (systolic blood pressure of less than 90 mmHg, and a heart rate of less than 40 bpm), agitation requiring sedation, and severe mask intolerance.
Statistical analysis
All variables were analyzed using SPSS (21.0; SPSS Inc., Chicago, IL, USA). Continuous variables were compared using Student's t test or Mann-Whitney test depending on the distribution of data, and categorical variables were compared using v 2 test. Variables considered statistically significant in the univariate analysis were entered into multivariate logistic regression analysis and their odds ratios with 95 % confidence interval are also shown. A P value of less than 0.05 was considered significant, and all P values were two sided. This study was approved by the Asan Medical Center Institutional Review Board.
Results
A total of 524 patients received NIV in the ED during the 7-year study period. After excluding 306 patients for other indications, 218 patients with acute exacerbation of COPD were finally included for the analysis. Reasons for exclusion were heart failure (n = 58), lung cancer (n = 49), motor neuron disease (n = 45), bronchiectasis (n = 40), tuberculous destroyed lung (n = 39), interstitial lung disease (n = 36), and bronchial asthma (n = 32). NIV was performed successfully in 200 (91.7 %) patients, and 18 (8.3 %) had early NIV failure. Of the 18 patients with early NIV failure requiring endotracheal intubation, 13 patients completed the treatment and survived and 5 patients died. Of the 200 patients who had successful NIV treatment, 14 died during the hospitalization (Fig. 1) .
On univariate analysis, APACHE II score and white blood cell count were associated with NIV failure. Higher heart rate and respiration rate before and 1 h after NIV were more common in patients who failed NIV than in whom NIV was successful. On blood gas analysis, lower pH before NIV and lower pH and HCO 3 -1 h after NIV were more common in patients who failed NIV ( Table 1) .
The multivariate logistic regression analysis demonstrated that, of the variables obtained before NIV treatment, heart rate (C120/min: OR 2.5, 95 % CI 1.2-7.0) and pH (7.25-7.29: OR 2.1, 95 % CI 1.0-8.8; \7.25: OR 11.7, 95 % CI 3.5-38.6) were significant factors associated with early NIV failure. Heart rate (C120/min: OR 7.5, 95 % CI 2.3-24.3) and pH (7.25-7.29: OR 4.7, 95 % CI 1.5-15.1; \7.25: OR 20.9, 95 % CI 5.4-61.2) obtained after 1 h of NIV treatment had a significant effect (Table 2 ). With a combination of different groups of heart rate (\120 and C120) and pH (C7.3, 7.25-7.29 and \7.25), a cross table was generated and failure rates in each combination were calculated ( Table 3 ). The NIV failure rate was 2.8 % when the patient had heart rate \120/min and pH C7.3 before and 1 h after NIV treatment. With heart rate C120/min and pH\7.25 before and 1 h after the treatment, the failure rate was 50.0 and 57.1 %, respectively.
Discussion
NIV provides significant advantages in the management of acute hypercapnic respiratory failure in COPD compared with invasive ventilation. However, some patients do not improve with NIV treatment, and in these patients endotracheal intubation is eventually performed. As patients who receive intubation after failure of NIV treatment experience high mortality, evaluation of the parameters predicting high risk of failure is required. Several factors are reported to be associated with NIV failures: severe acidosis, failure to improve PaCO 2 or the respiratory rate, high APACHE II score, radiological consolidation, hemodynamic instability, presence of comorbidities, and impaired consciousness [7, [13] [14] [15] . Although most of the early clinical trials excluded patients with a baseline pH of less than 7.25, more recent studies and a meta-analysis have shown that NIV is beneficial even in patients with more severe acidosis [7, 10, 16] . Despite this wide range of NIV application in acute exacerbations of COPD, the selection of the appropriate patient for NIV treatment is still difficult because of inconsistent results and diverse factors included in previous studies [8, 9, [17] [18] [19] [20] . For decisions regarding NIV management that must be made in the ED, parameters readily available in the ED are needed to be clinically useful. In this regard, we have focused on assessing the predictor variables for early failure during the patient's stay in the ED, including more severe patients compared with previous studies.
Our data show that pH and heart rate before and 1 h after the treatment with NIV are factors related to NIV failure in COPD; tachycardia ([120/min) is associated with NIV failure, and the more severe the acidosis, the more frequent is the occurrence of failure. Previous studies have emphasized the severity of acidosis as a significant parameter associated with NIV outcome. Confalonieri et al. developed a prediction model for NIV failure and showed that pH \7.25 at admission (OR 1.97, 95 % CI 1.23-3.15) and 2 h after treatment (OR 21.02, 95 % CI 10.07-43.87) are the main factors influencing the outcome [15] . In a study by Carratu et al., patients with early NIV failure showed no significant increase of pH after 2 h of NIV and the value of pH, along with GCS and APACHE II score were the best predictors of NIV failure [18] . In one randomized control trial, survival was worse when the initial pH was below 7.3 [7] . Miller et al. showed that higher pH at baseline and its improvement within 1 h are more likely to have a successful outcome [20] . In a study by Nicolini et al., pH on admission (OR 0.69, 95 % CI 0.50-0.95) and at 1 h after NIV (OR 0.48, 95 % CI 0.32-0.72) were independent variables with regard to hospital mortality [21] . However, some other studies have failed to show pH as an independent factor of NIV failure [8, 9, 17] . This NIV noninvasive ventilation, ABGA arterial blood gas analysis, WBC white blood cell, BUN blood urea nitrogen, CRP C-reactive peptide, BNP B-type natriuretic peptide discrepancy could be derived from inclusions in the study of different patients. Compared with studies that included patients with pH [7.25, our study did not limit inclusion based on pH, since nowadays NIV is offered to patients with more severe acidosis showing positive treatment results. Another thing to consider while interpreting the result is that using initial ABGA on presentation without information of NIV application time in the analysis may lead to erroneous results. In this regard, we have used the last ABGA results checked immediately before the initiation of NIV treatment, rather than the initial ones on the patients' presentation. Since the GOLD guidelines suggest a trial of NIV treatment for most patients, the decision to continue this treatment using parameters obtained after 1 h of NIV application might be crucial [12] . The significant variables in our study (heart rate and pH) were common factors included in both before and after 1 h of NIV treatment. However, ORs for each variable were higher in those obtained after the treatment. When a patient is still in acidosis and tachycardia even after 1 h of NIV, this might be a marker of great physical distress and failure to improve acidosis through support from NIV. Based on the above results, more focus on vital signs and blood gas analysis obtained 1 h after NIV treatment should be emphasized to predict NIV failure and to prevent improper delays of intubation in these patients.
In our study, the success rate for NIV was 91.7 % with an overall mortality rate of 8.7 %. Compared to previous studies reporting success rates of 66-81 % [8, 9, 15, 17, 19, 20] , our result was higher. This difference may be attributed to the different definitions of primary outcome: early failure vs. overall failure. In the same context, 14 patients with hospital death from the NIV success group could have been classified as NIV failure if the overall results were considered as the primary outcome. All 14 of these patients had a resolution from respiratory acidosis with successful weaning from NIV for more than 48 h. Among them, eight patients died of recurrent respiratory failure, four died of sepsis, one died of massive pulmonary embolism, and one died of gastrointestinal bleeding. All of these deaths were unpredictable during their stay in the ED, suggesting early outcome as a more appropriate goal in the ED-based study.
The main limitations of the present study are that it is a retrospective single-center study including only a small number of patients. Although management of acute exacerbation of COPD follows the protocol based on guidelines, the decision to discontinue NIV treatment or to perform endotracheal intubation was at the discretion of the treating physicians. We could not analyze more serial parameters such as 2, 4 and 24 h of follow-up data after NIV treatment. There might be doubts using pH\7.25 as a predictor variable of NIV failure, since the decision to intubate was based on clinical judgement including blood gas analysis values. However, in our analysis, the cutoff values of the variable pH was adopted based on previous studies, rather than derivation from our data set, which could rebut this circular argument [15] .
In conclusion, the presence of tachycardia and severe acidosis before NIV treatment are independent factors for NIV failure. The more severe the acidosis, the more probable is the failure of NIV. The persistence of tachycardia and severe acidosis after 1 h of NIV treatment is associated with early NIV failure with higher odds ratios.
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